Drug intelligence / Profile preview

metronidazole + diltiazem + lidocaine

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Topical
01

Overview

This is a topical combination medication containing metronidazole, diltiazem, and lidocaine used primarily for the treatment of acute anal fissures. The combination provides multiple therapeutic benefits: metronidazole acts as an antibiotic effective against anaerobic bacteria that may cause subclinical infection in anal fissures, diltiazem functions as a calcium channel blocker to relax the internal anal sphincter, and lidocaine provides local anesthetic effects to reduce pain. Clinical studies have shown that this combination therapy offers superior outcomes compared to conventional treatments alone, including faster pain reduction, improved healing rates, and decreased need for surgical intervention.

02

Targets

NaV (Voltage-gated sodium channels)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)

Beyond the preview

Go deeper on metronidazole + diltiazem + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metronidazole + diltiazem + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call